1. Framing Alert Whats worse, though, is the implication that research into adult cells and cord blood cells somehow replaces embryonic research. Adult stem cells and umbilical stem cells may serve the great function of curing some blood diseases and cancer, but theyre not a stand-in for embryonic cells. Theres obviously nothing wrong with advocating further research on adult stem cells, but claiming this position as sole property of the anti-abortion movement is disingenuous. This just made its way to our...
Source • 4 hours ago •
2. GenoLogics Announces Bioinformatics Partnership with Illumina The process is quick and simple and after completion you will have immediate access to these resources. By registering you can gain free access to our specialised content including: Links to additional resources. Specialist company contacts. New products and services. Audio presentations from recent conferences. GenomicsProteomics.com is a free to use portal for professionals in the field of Genomics and Proteomics. Posters from recent meetings.
Source • GenomicsProteomics.com (press release),UK •
3. Danish Investors Fund Bioinformatics Company Home Page . Free Subscription . Advertising . About HPCwire Breaking News: Danish Investors Fund Bioinformatics Company AARHUS, Denmark, July 3 -- CLC bio, the world's leading bioinformatics solution provider, announced today that the company has entered an agreement, which ensures a significant amount of additional financing from local Danish private investors. Home Page . Free Subscription . Advertising . About HPCwire Breaking News: Danish Investors Fund Bioinformatics Company AARHUS,...
Source • HPCwire,CA •
4. Biotech firms laud state for job boom While many of the state's industries are decrying the high taxes and difficult regulatory environment in New Jersey, biotechnology executives are singing a very different song. pharmaceutical industry, home to such stalwarts as Whitehouse Station-based Merck & co., New Brunswick-based Johnson & Johnson and Kenilworth-based Schering-Plough corp., the state's biotech industry has taken on a larger profile in recent years as innovation has increasingly bubbled up from these smaller, more...
Source • NorthJersey.com,NJ •
5. Growing Demand for Advanced Data Handling Tools in Drug Discovery ... Moreover, given the reducing drug pipelines in the European pharmaceutical industry, companies are looking for tools to increase drug research productivity. Apart from this, as various companies use different data formats, proprietary and incompatible data formats limit the value of bioinformatics. This demand from pharmaceutical and life sciences companies is another factor influencing the bioinformatics market favourably. Bioinformatics has been able to constantly develop new tools that...
Source • PR Newswire (press release),NY •
6. Heart disease hope in stem cells Now researchers at the University of Buffalo have tried using stem cells from bone marrow to generate new blood vessels from scratch outside the body. James Randerson Monday July 9, 2007 The Guardian A new technique for creating artificial blood vessels outside the body using a patient's own stem cells has offered hope for people with heart disease. Heart disease hope in stem cells. Article continues Heart bypass surgery involves taking a length of artery from elsewhere in the body -...
Source • 19 hours ago •
7. Utah announces new science adviser This student-led company assists high school and college students with internship opportunities for life science companies. Utah announces new science adviser. The Governor's Office of Economic Development has announced the appointment of Tamara Goetz as the state's new science adviser. Tamara Goetz Goetz worked as director of Salt Lake Community College's biotechnology program, where she helped to create a one-year high school biotechnology program. She also directed the nationally...
Source • •
8. Biotech compensation Perks such as housing and transportation allowances were taken into account in the review, though stock options and awards were not because they don't represent cash - something most biotech companies don't have to spare. Many of the 26 reporting companies don't yet have products on the market and just five of them recorded profits. Yet their chief executives earned average annual cash compensation of $611,312, according to a Sun analysis of figures found in regulatory filings....
Source • •
9. Indian biotech firms seek biotechnology breakthroughs to solve ... Indian biotech firms seek biotechnology breakthroughs to solve agrarian crisis. MOUTHS TO FEED: The development of BT cotton helped to turn India into a net cotton exporter, but some critics say the focus should be on food crops AFP, BANGALORE, INDIA Monday, Jun 18, 2007, Page 11 Metahelix Life Sciences, a biotech firm founded by five Indian scientists in 2001, says it is doing research that may lead to the development of insect-protected rice and high-yield corn. MOUTHS TO FEED: The...
Source • Taipei Times,Taiwan •
| ||||
| Archive [1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20] days ago | ||||